• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE PROPATEN VASCULAR GRAFT (STRETCH REMOVABLE RING); PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE PROPATEN VASCULAR GRAFT (STRETCH REMOVABLE RING); PROSTHESIS, VASCULAR GRAFT Back to Search Results
Catalog Number HT083040A
Device Problem Complete Blockage (1094)
Patient Problems Stroke/CVA (1770); Death (1802); Occlusion (1984)
Event Date 07/27/2018
Event Type  Death  
Event Description
The following was reported to gore: on (b)(6) 2018, a patient with a history of cabg x 4, cardiac stents x 3 presented with acute onset of chest pain, shortness of breath and generalized weakness.Patient was given nitroglycerin and she became unresponsive with seizure-like activity.Due to the nature of acute type, a dissection and risk of rupture, it was decided to not pursue emergent open repair given high risks of procedure.Patient was admitted for aggressive blood pressure and pain management.Over the next few days, the vascular surgery team decided to repair via endovascular approach.On (b)(6) 2018, the patient required 2u prbcs for anemia with concern for rupture due to hematemesis and melena.Patient underwent debranching with patent right common carotid to left subclavian artery graft with the left common carotid jump graft connection to this graft.As reported, an 8mm gore® propaten® vascular graft (thin walled removable ringed) was implanted during this procedure.In addition, thoracic aortic repair, stent graft placement in the innominate artery and implantation of a temporary transvenous pacemaker were performed.Egd (esophagogastroduodenoscopy) was completed post-op without ability to identify a source of bleeding.No active arterial extravasation or embolization were performed.On (b)(6) egd was repeated which again visualized a large organized clot at the distal portion of the stomach, but no active source of bleeding.Other post-operative complications include thrombocytopenia.On (b)(6) patient became hypotensive with dark melanotic colostomy output.Patient underwent cta on (b)(6) which demonstrated interval graft thrombosis as well as bilateral ischemic strokes and persistent gi bleeding.It was found the graft was occluded with thrombus.Graft thrombectomy was not considered due to ongoing contraindications to anticoagulation.Given patient's overall poor prognosis with minimal likelihood of meaningful recovery, care was withdrawn.Comfort care was provided and patient expired on (b)(6) 2018.As reported, cause of death is type a aortic dissection, gastric bleeding and stroke (thrombosis of carotid-subclavian bypass).Autopsy was not performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE PROPATEN VASCULAR GRAFT (STRETCH REMOVABLE RING)
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
genevieve begay
1500 n. 4th street
9285263030
MDR Report Key7831061
MDR Text Key118707625
Report Number2017233-2018-00524
Device Sequence Number1
Product Code DSY
UDI-Device Identifier00733132606801
UDI-Public00733132606801
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062161
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 07/31/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/29/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/06/2022
Device Catalogue NumberHT083040A
Device Lot Number5909690PP014
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/07/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age73 YR
Patient Weight68
-
-